+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

ANCA Vasculitis - Pipeline Insight, 2025 - Product Thumbnail Image

ANCA Vasculitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
22q11.2 Deletion Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

22q11.2 Deletion Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acute Cannabinoid Intoxication - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Cannabinoid Intoxication - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pneumococcal Pneumonia - Pipeline Insight, 2025 - Product Thumbnail Image

Pneumococcal Pneumonia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Neuromyelitis Optica - Pipeline Insight, 2025 - Product Thumbnail Image

Neuromyelitis Optica - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Acute Hepatic Porphyria (AHP) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Hepatic Porphyria (AHP) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hyperhidrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperhidrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Human Papillomavirus (HPV) - Pipeline Insight, 2025 - Product Thumbnail Image

Human Papillomavirus (HPV) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HPV-induced Cutaneous Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

HPV-induced Cutaneous Tumors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
House Dust Mite Allergy - Pipeline Insight, 2025 - Product Thumbnail Image

House Dust Mite Allergy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HIV-associated Lipodystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

HIV-associated Lipodystrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hereditary Hemochromatosis (HH) - Pipeline Insight, 2025 - Product Thumbnail Image

Hereditary Hemochromatosis (HH) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hay Fever Conjunctivitis - Pipeline Insight, 2025 - Product Thumbnail Image

Hay Fever Conjunctivitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Growth Hormone Deficiency (GHD) - Pipeline Insight, 2025 - Product Thumbnail Image

Growth Hormone Deficiency (GHD) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Dry AMD - Pipeline Insight, 2025 - Product Thumbnail Image

Dry AMD - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Post-surgical Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Post-surgical Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Interleukin-10 (IL-10) Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-10 (IL-10) Receptor Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-12 (IL-12) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-12 (IL-12) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more